- The Wall Street Journal•23 hours ago
Fusion Pharmaceuticals Inc. has raised $25 million in a bid to build on the success of a new radio-pharmaceutical from Bayer AG that extends life for certain prostate cancer patients.
Bayer AG's (BAYRY) fourth-quarter 2016 core earnings increased 10.2% year over year to ???1.19 per share (approximately $1.28). Reported earnings missed the Zacks Consensus Estimate of $1.37.
- The Wall Street Journal•yesterday
Bayer’s chief executive said he was confident the German firm’s planned $57 billion acquisition of Monsanto would overcome any regulatory obstacles and close by the end of the year, despite delays with ...
BAYA.F : Summary for BAYER ADR - Yahoo Finance
Bayer Aktiengesellschaft (BAYA.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
|Bid||104.10 x 12000|
|Ask||104.78 x 12000|
|Day's Range||102.88 - 105.39|
|52 Week Range||83.43 - 110.84|
|PE Ratio (TTM)||18.37|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|